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Abstract: The synthesis of four quinolone natural products
from the actinomycete Pseudonocardia sp. is reported. The key
step involved a sp2–sp3 Suzuki–Miyaura reaction between a
Introduction
Quinolone natural products have been noted for their biologi-
cal activities since the 1950s, and in the 1980s the introduction
of synthetic fluoroquinolones provided potent new antibiot-
ics.[1] More recently, quinolones have been found to play a role
in bacterial cell-cell signalling, known as quorum sensing (QS),
in the pathogen Pseudomonas aeruginosa[2] which produces
over 50 quinolones.[3] Since this discovery it has become appar-
ent that other bacterial species including Burkholderia and Alter-
monas spp. also produce quinolones.[4] Such findings have led
to the hypothesis that in the bacterial world quinolones may
play an underlying role in gene regulation and inter-species
modulation in complex multi-bacterial communities.[5,6] Intrigu-
ingly, both Burkholderia sp. and P. aeruginosa which can be
found in the natural environment, including soil and water
sources, are major pathogens in cystic fibrosis patients and
form mixed biofilms.[7] Quinolones produced by P. aeruginosa
have also been found to influence a number of phenotypes in
other bacterial species.[6]
Considering this role, and our research interests involving
quinolone signalling and bacterial signaling,[8] we became in-
terested in the natural quinolones produced by the actinomy-
cete Pseudonocardia sp. CL38489, isolated from a soil sample in
India by Dekker et al.[9] (Figure 1). A number of these quinolone
natural products were originally noted for their potent antibac-
terial activity against the Gram-negative bacteria Helicobacter
pylori, which is implicated in pathogenesis of chronic gastritis,
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common boronic ester lateral chain and various functionalised
quinolone cores. The quinolones slowed growth of E. coli and
S. aureus by inducing extended lag phases.
peptic ulcers and gastric cancers.[9] Quinolones 1–4 also bear
structural resemblance to a number of natural alkyl-substituted
quinolones produced by P. aeruginosa and Burkholderia spp.[3,4]
Figure 1. Four quinolone natural products isolated from Pseudonocardia sp.[9]
We envisaged a divergent total synthesis[10] that will be effi-
cient for the production of quinolone natural products 1–4 for
further biological evaluation of their effects on QS, inter-species
signaling, and antibacterial activities. The first total synthesis of
1 was recently reported by Abe et al.[11] when synthetic efforts
within our group was also aiming at these natural products.
Scheme 1. Retrosynthestic analysis of quinolones 1–4. Disconnection b
proved successful.
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Our retrosynthetic analysis of quinolones 1–4, similarly to Abe
et al., incorporated three main disconnection strategies (a, b
and c, Scheme 1). Disconnection (a) involved a final intramolec-
ular cyclisation step with 5 to set up the quinolone core. Dis-
connection (b) would require the preparation of halogen func-
tionalised quinolone building blocks 6 and a common boronic
ester lateral chain 7 that would be combined via palladium sp2–
sp3 coupling chemistry. Cross-couplings of this sort are notori-
ously challenging; however, this would enable a very expedient
and modular route towards the quinolone natural products that
should prove highly amenable to analogue preparation. Discon-
nection (c) required quinolone building blocks of the type 9
and the commercially available ketone 8, which could be con-
verted into the final quinolone natural products utilizing Wittig
chemistry.
Results and Discussion
Initial studies focused upon the exploration of disconnection
strategies (a) and (c) (Scheme 1). Unfortunately, these both
proved to be unsatisfactory. Under various cyclisation condi-
tions with intermediate 5 only the undesired pyridone regiosi-
omer could be detected and isolated. Preparation of the quinol-
one intermediate 10 was very low yielding as upon formation
of 10 elimination of the halogen readily occurred to give the
undesired alkene substituted quinolone.
Attempts to perform Wittig chemistry between 8 and 9 re-
sulted in complex mixtures, with no detected desired product.
Attention thus shifted towards disconnection strategy (b),
which was initially regarded as being the more challenging of
the three proposed options. 5-Bromo-2-methyl-pent-2-ene 11
which could be purchased, or readily prepared by literature pro-
cedure,[12] served as the starting material for the synthesis of
the lateral chain 7 (Scheme 2). Compound 11 was subjected to
an SN2 reaction with lithium acetylide to afford the alkyne
12.[13] Zr-catalysed carboalumination followed by reaction with
iodine generated compound 13 as a single stereoisomer in
modest yield.[14] The last step was the formation of the pinacol-
boronate 7 via the Miyaura borylation reaction, a single stereo-
isomer was isolated and the desired (E) geometry was confirmed
by NOESY analysis. For the synthesis of the quinolone building
blocks for natural products 1–3, esters 17–19 were synthesized
Scheme 2. Preparation of common boronic ester lateral chain.
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in a two-step sequence, utilizing the Conrad–Limpach method
in good to moderate yields (Scheme 3).[15] The subsequent re-
duction of esters 17–19 in the presence of lithium aluminium
hydride or sodium borohydride afforded the alcohols 20–22 in
good yields. Lithium aluminum hydride proved to be a non-
chemo selective reducing agent in the case of N-methyl-substi-
tuted quinolone 19, with reduction of both the quinolone core
and the ester group observed. Substitution of the hydroxy
group of 20–22 by chlorination with thionyl chloride led to the
formation of the halide substituted quinolone cores 23–25 in
good yields. Unfortunately, the dimethyl-substituted quinolone
core 29, required for quinolone natural product 4, could only
be prepared in poor yields using the Conrad–Limpach reaction
that was utilized for the formation of esters 17–19.
Scheme 3. Preparation of quinolone cores for natural products 1–3. For full
experimental details see the Supporting Information.
Thus, an alternative strategy was employed for the synthesis
of 4, based upon the use of compound 20. The hydroxy group
of 20 was protected with TBDMS-Cl to afford the desired silyl
ether in good yield (Scheme 4). Methylation of the nitrogen
resulted in the formation of 27 in moderate yield; the O-methyl-
ated regioisomer of 27 was also detected as a side product.
Deprotection of 27 using TBAF and chlorination using thionyl
chloride afforded 29 in good yield.
With the halide substituted quinolones 23, 24, 25, 29 and
pinacolborate 7 in hand, we were ready to attempt the key
Suzuki–Miyaura coupling reaction (Scheme 5). Pleasingly, mi-
crowave irradiation of a suspension of 7, quinolone 23, 24, 25
or 29, sodium carbonate and tetrakis(triphenylphosphine)palla-
dium(0) in 1,4-dioxane led to the formation of desired products
1–4 respectively in good to moderate yields, aside from 2 (final
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Scheme 4. Preparation of dimethyl-substituted quinolone core.
purification of 2 for biological testing proved particularly chal-
lenging), however significant quantities were obtained for bio-
logical studies. The four natural products 1–4 were obtained
with high levels of purity and stereoselectivity (≥ 99 % E-select-
ivity; the E-geometry of the double bond was confirmed by
NOESY analysis). The bromine analogues of quinolones 23, 24,
25 and 29 were also prepared however there was no significant
improvement in yield of the final coupling step compared to
the chlorine substituted quinolones.
Scheme 5. Preparation of quinolone natural products 1–4.
With the natural products in hand we next sought to investi-
gate their effects on quinolone signaling on other bacterial spe-
cies. Our initial assay involved focusing on PqsR (also known as
MvfR), the receptor protein utilized by P. aeruginosa for quinol-
one mediated signalling, in a heterologous E. coli system.[16,8b]
The natural products 1–4 failed to modulate PqsR dependent
transcriptional activity in any agonistic or antagonistic fashion
(data not shown). However, it cannot be ruled out that other
phenotypes independent of PqsR could be modulated by ana-
logues 1–4, as Burklhoderia and Altermonas spp produce quin-
olones but no PqsR homologue has been identified to date.
Inspired by the antibacterial activities of compounds 1–4
against Helicobacter pylori, we decided to screen the natural
products to see if they had any noticeable bioactivity in a range
of bacterial species. We initially screened four bacterial species;
Pseudomonas aeruginosa wild-type strain PA01, Staphylococcus
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Figure 2. Growth profile of bacterial species in presence of natural products
1–4. Error bars represent standard deviation of triplicate cultures. As a control
growth was also measured in the presence of solvent DMSO alone and in
the presence of a known antibiotic gentamicin. The compounds were tested
at 200 μM.
aureus 25923, Escherichia coli ESS (Figure 2) and Serratia marces-
cens 274 (data not shown). The growth of P. aeruginosa and S.
marcescens were not affected by the presence of the natural
products. Intriguingly, there was a large effect on the growth
of the E. coli and S. aureus strains;[17] however this effect was
notably different to the gentamicin control (which prevented
growth of all the species tested).
In S. aureus cultures, all four natural products caused a
marked delay in the onset of growth. A similar effect was ob-
served in E. coli, although natural product 3 was inactive. This
observed delay in the onset of growth resembles an extended
lag phase in the growth profile of the bacteria. Thus, quinolones
1–4 are slowing growth (decreased OD600 values for the first 6
hours of growth compared to the DMSO control) rather than
directly inhibiting growth (bacteriostatic antibiotic) or killing
the bacteria (bacteriolytic antibiotic). In the case of a bacterio-
lytic or bacteriostatic antibiotic, similar to the gentamicin con-
trol, growth would be completely inhibited over the 8 hour
period. Toyofuku and co-workers have reported that the struc-
turally related signalling molecule utilized by P. aeruginosa [2-
heptyl-3-hydroxy-4(1H)-quinolone] also known as the Pseudo-
monas Quinolone Signal (PQS), also effects the growth of sev-
eral Gram-negative and Gram-positive bacterial species by
slowing growth and inducing an extended lag phase.[18] Al-
though the underlying biochemical basis for this induced ex-
tended lag phase is not known, it is tempting to speculate that
the quinolones may be interfering with the electron transport
chain and affecting cellular respiration, as has previously been
reported for other quinolone natural products.[19] Previous
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studies have also shown that the uptake of hydrophobic quinol-
one antibiotics by S. aureus and E. coli occurs by passive diffu-
sion, whereas uptake by P. aeruginosa was found to be more
complex.[20] An inadequate uptake may explain why P. aerugi-
nosa showed to be insensitive to the tested natural products.
One hypothesis for the observed growth defect by the natural
product quinolones such as 1–4, PQS and possibly other natural
quinolones produced by bacteria, is that such quinolones could
be functioning in multi-bacterial communities in the natural en-
vironment to perturb the growth of competing bacterial spe-
cies.
Conclusions
In conclusion we have developed an efficient and direct syn-
thetic route to four quinolone natural products 1–4 produced
by the actinomycete Pseudonocardia sp. The route involved a
traditionally challenging sp2–sp3 Suzuki step between various
functionalised quinolone cores and a common lateral chain,
which proceeded in high stereoselectivity. The quinolone core
building blocks and lateral chain could be readily prepared from
easily accessible starting materials (longest linear sequence of
four steps). It was established that the natural products 1–4 do
not interfere with signalling by the quinolone receptor protein
PqsR of P. aeruginosa. However, similar to PQS the natural pro-
ducts were found to slow the growth of other bacterial species,
including E. coli and S. aureus. Further studies of such quinol-
ones and their biological activities in bacterial species should
lead to a greater understanding of inter-species signaling in the
natural environment and potential novel antibacterial agents.
Experimental Section
Supporting Information (see footnote on the first page of this
article): Full experimental protocols, characterisation data, and 1H
and 13C NMR spectra.
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